4 ms·
> From 1922 until 1981, the only insulins available commercially were extracted from bovine and porcine pancreases -- a process which was both expensive and dan
by gwern 12y ago
> From 1922 until 1981, the only insulins available commercially were extracted from bovine and porcine pancreases -- a process which was both expensive and dangerous
From the medical paper being summarized in OP:
"A series of innovations in the insulin manufacturing process in the early 1970s helped to improve purity and reduce these side effects. In short succession,
Novo introduced “monocomponent” insulins and
Lilly introduced “single-peak” insulins. These
safety improvements extended insulin patents
into the late 1980s...Although recombinant insulin was heavily advertised as a clinically superior
agent in the 1980s (Fig. 1), almost no evidence
was provided to demonstrate its superiority to
the best available animal-extract insulins. 26"
> This makes it act roughly twice as fast as regular insulin, roughly matching the time taken for a meal to be digested and to enter the bloodstream -- thus reducing the postprandial "peak" and cutting down on the chronic hyperglycaemia related complications of diabetes...but it wasn't until 2003 that the first "24 hour" insulin was released.
From the medical paper:
"Although long-acting analogues cause less hypoglycemia than NPH does, 27 it has yet to be shown that analogues lead to better long-term outcomes than standard recombinant human insulin does. 28"
> Because the insulin we're using now is a heck of a lot better than the insulin 90 years ago.
"On the whole, insulin today is
demonstrably safer and more convenient to use
than products available in 1923. But whether
each incremental innovation is worth the price
we pay, in a world where insulin remains unaffordable to many patients with diabetes, is less
certain."
Tesla vs Model T?
- cperciva 12y ago"Although long-acting analogues cause less hypoglycemia than NPH does, 27 it has yet to be shown that analogues lead to better long-term outcomes than standard recombinant human insulin does. 28" Doctors vs. patients. Regardless of what doctors may think, as a patient I can assure you that not randomly passing out due to hypoglycaemia is a better outcome. Similarly taking one shot of basal insulin per day is better than three shots per day. "On the whole, insulin today is demonstrably safer and more convenient to use than products available in 1923. But whether each incremental innovation is worth the price we pay, in a world where insulin remains unaffordable to many patients with diabetes, is less certain." Bovine and porcine insulins didn't go away simply because newer insulins were more profitable. They went away because 99.9% of patients didn't want them any more.
- gwern 12y ago> Regardless of what doctors may think, as a patient I can assure you that not randomly passing out due to hypoglycaemia is a better outcome. I think you are exaggerating. Cite please. You also aren't addressing the other points: you claimed animal insulin was extremely dangerous and this justifies the continued monopoly through recombinant patents, when the paper specifically says that almost all of that safety problem had been dealt with. > Bovine and porcine insulins didn't go away simply because newer insulins were more profitable. That's pretty much what the paper argues, actually...